文献速递慢性肾脏病血液净化与透析

晚期慢性肾脏病患者经连续血糖监测评估的低血糖发生频率

Frequency of Hypoglycemia Assessed by Continuous Glucose Monitoring in Advanced CKD.
PubMed 文献 · Clin J Am Soc Nephrol · 2023-03-03

本横断面研究纳入366例慢性肾脏病G3-G5期(含血液透析)患者及无慢性肾脏病的2型糖尿病患者,进行7天间歇扫描式连续血糖监测。结果显示血糖<54 mg/dl在慢性肾脏病合并糖尿病者中占41%、慢性肾脏病非糖尿病者中占48%、无慢性肾脏病糖尿病者中占14%,仅2例报告低血糖症状;肾功能越差,低血糖负担越大。

要点

  • 慢性肾脏病合并糖尿病者41%出现血糖<54 mg/dl,非糖尿病慢性肾脏病者48%,无慢性肾脏病糖尿病者14%。
  • 7天血糖<70 mg/dl曲线下面积:血液透析组较CKD G4-G5组低0.25 min·mg/dl每小时(95%CI -6.40至-0.59),P<0.001。
  • 仅2例在监测期间报告低血糖症状,并经毛细血管血糖证实。

核心结论

  • 肾功能下降程度与慢性肾脏病患者低血糖负担强烈相关。

研究设计与样本

  • 横断面研究,纳入慢性肾脏病G3-G5期(含血液透析)门诊患者及无慢性肾脏病的2型糖尿病患者,进行7天间歇扫描式连续血糖监测。

主要发现

  • 共366例参与者:慢性肾脏病合并糖尿病148例,慢性肾脏病非糖尿病115例,无慢性肾脏病糖尿病103例。
  • 血糖<54 mg/dl在慢性肾脏病合并糖尿病者中占41%,慢性肾脏病非糖尿病者中占48%,无慢性肾脏病糖尿病者中占14%。
  • 仅2例在连续血糖监测期间报告低血糖症状,并经毛细血管血糖测量证实和记录。
  • 7天血糖<70 mg/dl曲线下面积组间差异:血液透析组与CKD G4和G5组比较为-0.25 min·mg/dl每小时(95%CI -6.40至-0.59),P<0.001;CKD G4和G5组与CKD G3组比较为-0.08 min·mg/dl每小时(95%CI -0.0至-0.50),P=0.15;CKD G3组与无慢性肾脏病糖尿病组比较为-0.14 min·mg/dl每小时(95%CI -0.0至-0.20),P=0.01。
  • 糖尿病或非糖尿病及日间或夜间的亚组分析显示,肾功能越差,7天血糖<70 mg/dl曲线下面积和血糖<54 mg/dl时间越大。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Hypoglycemia represents a risk for serious morbidity. We evaluated the prevalence and risk factors of hypoglycemia by continuous glucose monitoring (CGM) in patients with CKD with or without diabetes. METHODS: In this cross-sectional study, outpatients with CKD stages G3-G5 (including hemodialysis) and type 2 diabetes without CKD were enrolled and underwent intermittently scanned CGM measurements for 7 days. The burden of CGM-measured hypoglycemia was assessed using the 7-day sum of area over the curve with glucose levels <70 mg/dl and the sum of time spent <54 mg/dl. RESULTS: A total of 366 participants (148 participants with CKD and diabetes, 115 with CKD and without diabetes, and 103 without CKD and with diabetes) were included. Glucose levels of <54 mg/dl were observed in 41% of participants with CKD and diabetes, 48% of participants with CKD and without diabetes, and 14% of participants with diabetes and without CKD. However, only two participants reported hypoglycemic symptoms during CGM measurements, which were confirmed and documented by capillary blood glucose measurements. Between-group differences of 7-day area over the curve (<70 mg/dl) were as follows: hemodialysis group versus CKD stage G4 and G5 groups, -0.25 min·mg/dl per hour (95% confidence interval [CI], -6.40 to -0.59) P <0.001; CKD stage G4 and G5 groups versus CKD stage G3 group, -0.08 min·mg/dl per hour (95% CI, -0.0 to -0.50) P =0.15; and CKD stage G3 group versus diabetes without CKD group, -0.14 min·mg/dl per hour (95% CI, -0.0 to -0.20) P =0.01. In addition, the subgroup analysis of the diabetic or nondiabetic and at daytime or nighttime showed that the 7-day area over the curve (<70 mg/dl) and time spent (<54 mg/dl) was larger with worse kidney function. CONCLUSIONS: The lowering level of kidney function was strongly associated with the burden of hypoglycemia in patients with CKD.

来源:Clin J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Ushiogi Y, Kanehara H, Kato T, et al. Frequency of Hypoglycemia Assessed by Continuous Glucose Monitoring in Advanced CKD. Clin J Am Soc Nephrol. 2023. PMID: 36723294. doi:10.2215/CJN.0000000000000102

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。